Efficient CRISPR/Cas9 genome editing with Citrus embryogenic cell cultures

被引:29
|
作者
Dutt, Manjul [1 ]
Mou, Zhonglin [2 ]
Zhang, Xudong [2 ]
Tanwir, Sameena E. [1 ]
Grosser, Jude W. [1 ]
机构
[1] Univ Florida, Ctr Citrus Res & Educ, Lake Alfred, FL 33850 USA
[2] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA
关键词
Agrobacterium tumefaciens; CRISPR; Cas9; Citrus cell suspensions; Genetic transformation; AGROBACTERIUM-MEDIATED TRANSFORMATION; GENETIC-TRANSFORMATION; TARGETED MUTAGENESIS; SUSPENSION-CULTURES; DUNCAN GRAPEFRUIT; RNA; REGENERATION; PLANTS; ARABIDOPSIS; EXPRESSION;
D O I
10.1186/s12896-020-00652-9
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background Development of precise genome editing strategies is a prerequisite for producing edited plants that can aid in the study of gene function and help understand the genetic traits in a cultivar. Citrus embryogenic cell cultures can be used to rapidly produce a large population of genome edited transformed citrus lines. The ability to introduce specific mutations in the genome of these cells using two constructs (pC-PDS1 and pC-PDS2) was evaluated in this study. Results Citrus sinensis 'EV2' embryogenic cell cultures are amenable to Agrobacterium-mediated CRISPR/Cas9-based genome editing. Guide RNAs (gRNAs) targeting two locations in the phytoene desaturase (PDS) gene were either driven by the Arabidopsis U6-26 promoter (pC-PDS1) or assembled as a Csy4 array under the control of the CmYLCV promoter (pC-PDS2). All transgenic embryos were completely albino and no variegated phenotype was observed. We evaluated 12 lines from each construct in this study and the majority contain either insertion (1-2 bp), substitution (1 bp), or deletion (1-3 bp) mutations that occurred close to the protospacer adjacent motif. Conclusions Both the pC-PDS1 and pC-PDS2 could successfully edit the citrus embryogenic cell cultures. However, the editing efficiency was dependent on the gRNA, confirming that the selection of a proper gRNA is essential for successful genome editing using the CRISPR/Cas9 technique. Also, utilization of embryogenic cell cultures offers another option for successful genome editing in citrus.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Efficient CRISPR/Cas9 Genome Editing of Phytoene desaturase in Cassava
    Odipio, John
    Alicai, Titus
    Ingelbrecht, Ivan
    Nusinow, Dmitri A.
    Bart, Rebecca
    Taylor, Nigel J.
    FRONTIERS IN PLANT SCIENCE, 2017, 8
  • [22] Efficient CRISPR–Cas9 mediated multiplex genome editing in yeasts
    Laiyou Wang
    Aihua Deng
    Yun Zhang
    Shuwen Liu
    Yong Liang
    Hua Bai
    Di Cui
    Qidi Qiu
    Xiuling Shang
    Zhao Yang
    Xiuping He
    Tingyi Wen
    Biotechnology for Biofuels, 11
  • [23] Efficient Genome Editing in Apple Using a CRISPR/Cas9 system
    Chikako Nishitani
    Narumi Hirai
    Sadao Komori
    Masato Wada
    Kazuma Okada
    Keishi Osakabe
    Toshiya Yamamoto
    Yuriko Osakabe
    Scientific Reports, 6
  • [24] Efficient multiplex genome editing by CRISPR/Cas9 in common wheat
    Li, Jihu
    Zhang, Shujuan
    Zhang, Rongzhi
    Gao, Jie
    Qi, Yiping
    Song, Guoqi
    Li, Wei
    Li, Yulian
    Li, Genying
    PLANT BIOTECHNOLOGY JOURNAL, 2021, 19 (03) : 427 - 429
  • [25] Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
    Zhang, Song
    Shen, Jiangtao
    Li, Dali
    Cheng, Yiyun
    THERANOSTICS, 2021, 11 (02): : 614 - 648
  • [26] CRISPR/CAS9 GENOME EDITING FOR NEURODEGENERATIVE DISEASES
    Nojadeh, Jafar Nouri
    Eryilmaz, Nur Seren Bildiren
    Erguder, Berrin Imge
    EXCLI JOURNAL, 2023, 22 : 567 - 582
  • [27] CRISPR/CAS9, the king of genome editing tools
    A. V. Bannikov
    A. V. Lavrov
    Molecular Biology, 2017, 51 : 514 - 525
  • [28] Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
    Duan, Li
    Ouyang, Kan
    Xu, Xiao
    Xu, Limei
    Wen, Caining
    Zhou, Xiaoying
    Qin, Zhuan
    Xu, Zhiyi
    Sun, Wei
    Liang, Yujie
    FRONTIERS IN GENETICS, 2021, 12
  • [29] Advances in therapeutic CRISPR/Cas9 genome editing
    Schwank, G.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1053 - 1053
  • [30] CRISPR/CAS9, the King of Genome Editing Tools
    Bannikov, A. V.
    Lavrov, A. V.
    MOLECULAR BIOLOGY, 2017, 51 (04) : 514 - 525